Winner Medical Co., Ltd. (SHE:300888)
China flag China · Delayed Price · Currency is CNY
35.71
+0.14 (0.39%)
At close: Feb 27, 2026

Winner Medical Ratios and Metrics

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Feb '26 Dec '24 Dec '23 Jan '23 Jan '22 Dec '20
20,79524,50421,88930,01135,16470,798
Market Cap Growth
-12.37%11.95%-27.06%-14.65%-50.33%-
Enterprise Value
20,47722,17716,93625,71128,69963,672
Last Close Price
35.7141.4135.5347.1653.56106.28
PE Ratio
23.8335.2437.7118.1828.3718.58
Forward PE
19.9726.3811.5318.0417.1328.43
PS Ratio
1.922.732.672.644.385.65
PB Ratio
1.702.061.812.463.296.76
P/TBV Ratio
2.262.782.263.113.386.91
P/FCF Ratio
27.7767.1670.5516.82273.8216.88
P/OCF Ratio
14.0119.3620.5910.0640.3414.85
EV/Sales Ratio
1.902.472.072.273.575.08
EV/EBITDA Ratio
12.0919.4417.0612.5522.4312.95
EV/EBIT Ratio
18.6728.0425.0114.4325.7913.38
EV/FCF Ratio
27.3560.7854.5914.41223.4815.18
Debt / Equity Ratio
0.230.250.180.230.060.01
Debt / EBITDA Ratio
1.632.131.791.250.400.03
Debt / FCF Ratio
3.697.977.021.594.660.04
Net Debt / Equity Ratio
-0.09-0.15-0.44-0.51-0.64-0.78
Net Debt / EBITDA Ratio
-0.74-1.55-5.42-3.01-5.36-1.66
Net Debt / FCF Ratio
-1.46-4.84-17.33-3.46-53.39-1.94
Asset Turnover
0.590.510.460.720.611.43
Inventory Turnover
2.822.882.944.022.934.72
Quick Ratio
1.061.132.021.884.133.96
Current Ratio
1.691.532.472.214.994.53
Return on Equity (ROE)
7.63%6.18%5.17%14.63%11.70%56.08%
Return on Assets (ROA)
3.77%2.78%2.39%7.07%5.29%33.93%
Return on Invested Capital (ROIC)
7.90%7.66%8.90%31.54%30.59%153.44%
Return on Capital Employed (ROCE)
8.10%6.00%5.30%14.00%9.90%45.00%
Earnings Yield
4.20%2.84%2.65%5.50%3.52%5.38%
FCF Yield
3.60%1.49%1.42%5.95%0.36%5.92%
Dividend Yield
1.41%1.57%1.41%2.88%1.68%1.69%
Payout Ratio
52.17%59.34%141.56%24.29%61.98%2.69%
Buyback Yield / Dilution
0.69%1.33%-0.10%0.77%-9.42%-3.31%
Total Shareholder Return
2.09%2.90%1.31%3.65%-7.74%-1.61%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.